ACCORD HLTHCARE FDA Approval ANDA 204615

ANDA 204615

ACCORD HLTHCARE

FDA Drug Application

Application #204615

Application Sponsors

ANDA 204615ACCORD HLTHCARE

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUSEQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)0PALONOSETRON HYDROCHLORIDEPALONOSETRON HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2021-03-15STANDARD

Submissions Property Types

ORIG1Null19

TE Codes

001PrescriptionAP

CDER Filings

ACCORD HLTHCARE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204615
            [companyName] => ACCORD HLTHCARE
            [docInserts] => ["",""]
            [products] => [{"drugName":"PALONOSETRON HYDROCHLORIDE","activeIngredients":"PALONOSETRON HYDROCHLORIDE","strength":"EQ 0.25MG BASE\/5ML (EQ 0.05MG BASE\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/15\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-03-15
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.